- Trials with a EudraCT protocol (388)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (55)
388 result(s) found for: Dermatology.
Displaying page 1 of 20.
EudraCT Number: 2014-005593-11 | Sponsor Protocol Number: DIA_AD/2015 | Start Date*: 2015-02-24 |
Sponsor Name:University Hospital of Dermatology, Paracelsus Medical University | ||
Full Title: Diacerein for the treatment of atopic dermatitis | ||
Medical condition: Atopic dermatitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-002730-36 | Sponsor Protocol Number: CaEP68962 | Start Date*: 2019-11-14 | ||||||||||||||||
Sponsor Name:Department of Dermatology, Bispebjerg Hospital | ||||||||||||||||||
Full Title: Calcium electroporation for basal cell carcinomas – a ’Proof of concept’ study | ||||||||||||||||||
Medical condition: Basal cell carcinomas | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2014-005235-13 | Sponsor Protocol Number: PDTofAcne24.11.2014.version1 | Start Date*: 2015-02-10 | |||||||||||
Sponsor Name:Sahlgrenska University hospital of gothenburg Department of dermatology | |||||||||||||
Full Title: Therapy-treatment (PDT) on Acne, a study to optimize the number of treatments, the right light-dose and the right pre-treatment in order to obtain a longterm remission-time | |||||||||||||
Medical condition: Acne | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-002029-40 | Sponsor Protocol Number: 1001 | Start Date*: 2013-08-23 |
Sponsor Name:Karolinska Institutet | ||
Full Title: Aprepitant – effect and safety in treatment of atopic dermatitis | ||
Medical condition: Atopic Dermatitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-004338-13 | Sponsor Protocol Number: TOPIC | Start Date*: 2019-06-11 | |||||||||||
Sponsor Name:Department of Dermatology, Erasmus University Medical Center | |||||||||||||
Full Title: Short term clinical efficacy of topical treatment with clindamycin-benzoyl peroxide gel compared with clindamycin lotion in mild to moderate Hidradenitis Suppurativa | |||||||||||||
Medical condition: Hidradenitis Suppurativa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001440-38 | Sponsor Protocol Number: 42647 | Start Date*: 2014-05-22 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Methods to increase PpIX formation in the skin of healthy volunteers | |||||||||||||
Medical condition: Healthy volunteers - no medical condition is investigated but pharmaco kinetics | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-002644-23 | Sponsor Protocol Number: MB_PDT_1 | Start Date*: 2020-07-23 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Dept. of Dermatology, Zealand University Hospital, Roskilde | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Photodynamic therapy of antifungal resistant dermatophytes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Competent patients over 18 years old with mycological verified antifungal resistant dermatophytosis | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000096-36 | Sponsor Protocol Number: Botox-01 | Start Date*: 2021-06-23 | |||||||||||
Sponsor Name:Department of Dermatology and Copenhagen Wound Healing Center, Bispebjerg Hospital | |||||||||||||
Full Title: The effect of subcutaneous injection of Botulinum Toxin A on chronic wound pain in lower extremities, a prospective exploratory study | |||||||||||||
Medical condition: chronic wound pain and wound healing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-004281-19 | Sponsor Protocol Number: 1.5 | Start Date*: 2022-06-08 |
Sponsor Name:Region Stockholm Karolinska University Hospital (Dep. of Dermatology) | ||
Full Title: Investigator initiated clinical trial of dantrolene as a treatment for Darier disease | ||
Medical condition: Darier disease is a rare and severe autosomal dominant skin disorder. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004403-13 | Sponsor Protocol Number: PDT002/12 | Start Date*: 2013-08-27 |
Sponsor Name:Medizinische Universität Wien, Univ. Klinik für Dermatologie | ||
Full Title: Placebo-controlled cross-over study on the efficacy of a non-steroidal antirheumatic drug for pain reduction during photodynamic therapy of actinic keratoses | ||
Medical condition: actinic keratosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2004-004258-26 | Sponsor Protocol Number: 02_2004 | Start Date*: 2005-06-23 |
Sponsor Name:University Clinic of Dermatology Division of Special and Enviromental Dermatology | ||
Full Title: Photodynamic Therapy (PDT) vs Chemopeeling for the treatment of multiple actinic keratoses on the underarms | ||
Medical condition: Actinic Keratosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-004002-10 | Sponsor Protocol Number: UFD-DESIC-001 | Start Date*: 2012-12-10 |
Sponsor Name:Department of Dermatology and Allergology, University of Szeged | ||
Full Title: Comparison of the effectiveness of desloratadine monotherapy and the combined cinnarizine and iprazochrome therapy for the treatment of urticaria factitia | ||
Medical condition: Among physical urticaria patients about 20-30% have urticaria factitia. The pathomechanism of urticaria factitia is not clear. Antihistamines are used to treat the condition, and this is in accorda... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: HU (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003020-31 | Sponsor Protocol Number: 24-08-2015version3.0 | Start Date*: 2015-09-03 | |||||||||||
Sponsor Name:Department of Dermatology, Bispebjerg University Hospital | |||||||||||||
Full Title: Pulse-Daylight-Photodynamic Therapy of Actinic Keratoses | |||||||||||||
Medical condition: Actinic keratoses | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002756-11 | Sponsor Protocol Number: 43739 | Start Date*: 2014-08-27 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Photodynamic therapy with varying application times for treatment of actinic keratosis | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000416-24 | Sponsor Protocol Number: CRC-ACNE-A-05 | Start Date*: 2013-06-21 |
Sponsor Name:Charité-Universitätsmedizin Berlin, Department of Dermatology, Clinical Research Center for Hair and Skin Science | ||
Full Title: THE EFFECT OF AZELAIC ACID ON SYMPTOMS OF ACNE IN FEMALE PATIENTS AGE 20-45 WITH MILD TO MODERATE PAPULOPUSTULAR ACNE (ACNE TARDA) | ||
Medical condition: MILD TO MODERATE PAPULOPUSTULAR ACNE (ACNE TARDA) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2015-003003-29 | Sponsor Protocol Number: 49301 | Start Date*: 2015-08-31 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: 5-flourouracil treatment prior to photodynamic therapy of actinic keratosis on the hands | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000762-65 | Sponsor Protocol Number: CAIN457ADE01T | Start Date*: 2015-07-09 | |||||||||||
Sponsor Name:Technische Universität München, School of Medicine, represented by Dean | |||||||||||||
Full Title: Single-arm study to assess a potential effect of anti-IL-17 (Secukinumab) in the treatment of pyoderma gangrenosum | |||||||||||||
Medical condition: Pyoderma gangrenosum is an autoinflammatory disease, characterized by relapsing, painful ulcers of the skin. Treatment of PG is difficult. Patients suffer from long hospitalization, pain and redu... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-005084-14 | Sponsor Protocol Number: 56297 | Start Date*: 2017-01-23 | |||||||||||
Sponsor Name:Deoartment of Dermatology D92, Bispbjerg Hospital | |||||||||||||
Full Title: PpIX in curetted and non-curetted skin after Metvix application | |||||||||||||
Medical condition: Actinic keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-003828-23 | Sponsor Protocol Number: ML39310 | Start Date*: 2017-04-11 | |||||||||||
Sponsor Name:Charité - Universitätsmedizin Berlin; Dpt. of Dermatology and Allergy | |||||||||||||
Full Title: A pilot open-label study to assess the efficacy and safety of tocilizumab (TCZ) in patients with active Schnitzler’s syndrome (SchS) | |||||||||||||
Medical condition: Schnitzler’s syndrome (SchS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-000746-22 | Sponsor Protocol Number: 874-2017 | Start Date*: 2017-06-22 |
Sponsor Name:Department of Dermatology, Zealand University Hospital, Roskilde | ||
Full Title: Vascular changes in basal cell carcinoma undergoing either electrochemotherapy or photodynamic therapy - assessed with optical coherence tomography | ||
Medical condition: Basal cell carcinoma in adults | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DK (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
